Bone marrow cell cycle markers in inherited bone marrow failure syndromes

Leukemia Research

Volumn 32, Issue 12, 2008, Pages 1793-1799

  Al Rahawan, Mohamad M ^a,b   Alter, Blanche P ^a   Bryant, Barbara J ^c   Elghetany, M Tarek ^d  

^a NATIONAL CANCER INSTITUTE   (United States)

^b CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Acute myeloid leukemia; Inherited bone marrow failure syndromes; Ki 67; Myelodysplastic syndrome; p53; Survivin

Indexed keywords

KI 67 ANTIGEN; PROTEIN P53;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; BONE MARROW CELL; BONE MARROW DEPRESSION; CELL CYCLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; RISK FACTOR;

BIOLOGICAL MARKERS; BIOPSY; BONE MARROW CELLS; BONE MARROW DISEASES; CELL CYCLE; FANCONI ANEMIA; HUMANS; KI-67 ANTIGEN; LEUKEMIA, MYELOID, ACUTE; MICROTUBULE-ASSOCIATED PROTEINS; MYELODYSPLASTIC SYNDROMES; NEOPLASM PROTEINS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 51649127441     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2008.05.020     Document Type: Article

References (20)

1. Alter B.P. Inherited bone marrow failure syndromes. In: Nathan D.G., Orkin S.H., Look A.T., and Ginsburg D. (Eds). Nathan and Oski's Hematology of Infancy and Childhood. 6th ed. (2003), WB Saunders, Philadelphia, PA 280
2. Alter BP. Diagnosis Genetics, and Management of Inherited Bone Marrow Failure Syndromes. Hematology American Society of Hematology Education Program 2007; 2007. p. 29.
3. Alter B.P. Bone marrow failure syndromes in children. Pediatr Clin N Am 49 (2002) 973-988
4. Vousden K.H., and Lane D.P. p53 in health and disease. Nat Rev Mol Cell Biol 8 (2007) 275-283
5. Fukuda S., and Pelus L.M. Regulation of the inhibitor-of-apoptosis family member survivin in normal cord blood and bone marrow CD34(+) cells by hematopoietic growth factors: implication of survivin expression in normal hematopoiesis. Blood 98 (2001) 2091-2100
6. Scholzen T., and Gerdes J. The Ki-67 protein: from the known and the unknown. J Cell Physiol 182 (2000) 311-322
7. Kurotaki H., Tsushima Y., Nagai K., and Yagihashi S. Apoptosis, bcl-2 expression and p53 accumulation in myelodysplastic syndrome, myelodysplastic-syndrome-derived acute myelogenous leukemia and de novo acute myelogenous leukemia. Acta Haematol 102 (2000) 115-123
8. Elghetany M.T., Vyas S., and Yuoh G. Significance of p53 overexpression in bone marrow biopsies from patients with bone marrow failure: aplastic anemia, hypocellular refractory anemia, and hypercellular refractory anemia. Ann Hematol 77 (1998) 261-264
9. Kanavaros P., Stefanaki K., Rontogianni D., Darivianaki K., Vlychou M., Papadaki E., et al. Immunohistochemical detection of p53, mdm2, waf1/p21, and Ki67 proteins in bone marrow biopsies in myelodysplastic syndromes, acute myelogenous leukaemias and chronic myeloproliferative disorders. Clin Exp Pathol 47 (1999) 231-238
10. Alexandrakis M.G., Passam F.H., Kyriakou D.S., Dambaki C., Katrinakis G., Tsirakis G., et al. Expression of the proliferation-associated nuclear protein MIB-1 and its relationship with microvascular density in bone marrow biopsies of patients with myelodysplastic syndromes. J Mol Histol 35 (2004) 857-863
11. Polak J., Hradcova M., Schwarz J., Klamova H., Stockbauer P., Kozak T., et al. Expression of cyclins D1, D2, and D3 and Ki-67 in leukemia. Leuk Lymphoma 46 (2005) 1605-1612
12. Adida C., Recher C., Raffoux E., Daniel M.T., Taksin A.L., Rousselot P., et al. Expression and prognostic significance of survivin in de novo acute myeloid leukaemia. Br J Haematol 111 (2000) 196-203
13. Yamamoto K., Abe S., Nakagawa Y., Suzuki K., Hasegawa M., Inoue M., et al. Expression of IAP family proteins in myelodysplastic syndromes transforming to overt leukemia. Leuk Res 28 (2004) 1203-1211
14. Elghetany M.T., and Alter B.P. p53 protein overexpression in bone marrow biopsies of patients with Shwachman-Diamond syndrome has a prevalence similar to that of patients with refractory anemia. Arch Pathol Lab Med 126 (2002) 452-455
15. Dror Y., Durie P., Ginzberg H., Herman R., Banerjee A., Champagne M., et al. Clonal evolution in marrows of patients with Shwachman-Diamond syndrome: a prospective 5-year follow-up study. Exp Hematol 30 (2002) 659-669
16. Venkatraj V.S., Gaidano G., and Auerbach A.D. Clonality studies and N-ras and p53 mutation analysis of hematopoietic cells in Fanconi anemia. Leukemia 8 (1994) 1354-1358
17. Hartsock R.J., Smith E.B., and Petty C.S. Normal variations with aging of the amount of hematopoietic tissue in bone marrow from the anterior iliac crest. A study made from 177 cases of sudden death examined by necropsy. Am J Clin Pathol 43 (1965) 326-331
18. Foucar K. Bone Marrow Pathology. 2 ed. (2001), ASCP Press, Chicago
19. In: Jaffe E.S., Harris N.L., Stein H., and Vardiman J.W. (Eds). World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues (2001), IARC Press, Lyon
20. Brada S.J.L., van de Loosdrecht A.A., Koudstaal J., de Wolf J., and Vellenga E. Limited numbers of apoptotic cells in fresh paraffin embedded bone marrow samples of patients with myelodysplastic syndrome. Leuk Res 28 (2004) 921-925